반응식
[C:1]([O:5][C:6]([N:8]1[CH2:15][CH2:14][N:13]([C:16]2[C:17]3[CH:24]=[CH:23][NH:22][C:18]=3[N:19]=[CH:20][N:21]=2)[CH2:12][C:9]21[CH2:11][CH2:10]2)=[O:7])([CH3:4])([CH3:3])[CH3:2].C(OC(N1C2CCC1CNC2)=O)(C)(C)C.C(OC(N1CCNCC21CC2)=O)(C)(C)C>>[C:1]([O:5][C:6]([N:8]1[CH:9]2[CH2:10][CH2:11][CH:15]1[CH2:14][N:13]([C:16]1[C:17]3[CH:24]=[CH:23][NH:22][C:18]=3[N:19]=[CH:20][N:21]=1)[CH2:12]2)=[O:7])([CH3:3])([CH3:4])[CH3:2]참가 물질
4
실험 절차
Prepared in a way similar to Intermediate 1, using 3,8-diaza-bicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester, instead of 4,7-diaza-spiro[2.5]octane-4-carboxylic acid tert-butyl ester.
출처 및 근거
- ORD 기록
- ord-480b82ed36624265aaf7d516d070a956
- 출처 데이터셋
- uspto-grants-2016_05
- 특허 번호
- US09346809B2
연결된 노트
불러오는 중…